Genenta Science SpA

Research Genenta Science SpA (GNTA) on Bullrun: market cap USD 42.46M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGNTA
• ExchangeNASDAQ
• CountryItaly
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 42.46M
• Financial periodQ4 2025
• Net income-USD 6.53M
• Free cash flow-USD 6.88M

Valuation Snapshot

latest market cap is USD 42.46M.

About Genenta Science SpA

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications.

Frequently asked questions

What is Genenta Science SpA's market cap?

Genenta Science SpA's market capitalization is USD 42.46M.

What does Genenta Science SpA do?

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.